These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24780059)

  • 21. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
    de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Pollicardo N; O'Brien S; Estey EH; al-Bitar M; Pierce S; Keating M; Kantarjian HM
    Leukemia; 1996 Jan; 10(1):27-31. PubMed ID: 8558933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemia.
    Tallman M; Lo-Coco F; Kwaan H; Sanz M; Gore S
    Clin Adv Hematol Oncol; 2011 Feb; 9(2):1-16. PubMed ID: 22379665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of acute promyelocytic leukaemia.
    Fenaux P; Chomienne C; Degos L
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):153-74. PubMed ID: 11355929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
    Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
    J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An epidemiological investigation of adult acute leukemia in Fujian Province in 2010].
    Clinical Collaborative Group, Hematological Branch of Fujian Medical Association
    Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):902-5. PubMed ID: 23363744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution.
    Matsuo K; Kiura K; Tabata M; Uchida A; Hotta K; Niiya D; Kubonishi S; Ogino A; Fujiwara Y; Nakajima H; Shinagawa K; Ishimaru F; Ueoka H; Tanimoto M
    Am J Hematol; 2006 May; 81(5):349-54. PubMed ID: 16628731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment advances have not improved the early death rate in acute promyelocytic leukemia.
    McClellan JS; Kohrt HE; Coutre S; Gotlib JR; Majeti R; Alizadeh AA; Medeiros BC
    Haematologica; 2012 Jan; 97(1):133-6. PubMed ID: 21993679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study.
    Firkin F
    Intern Med J; 2012 Aug; 42(8):948-52. PubMed ID: 22906029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen.
    Girmenia C; Lo Coco F; Breccia M; Latagliata R; Spadea A; D'Andrea M; Gentile G; Micozzi A; Alimena G; Martino P; Mandelli F
    Leukemia; 2003 May; 17(5):925-30. PubMed ID: 12750707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I; Rigal-Huguet F; Vekhoff A; Desablens B; Bordessoule D; Mounier C; Ferrant A; Sanz M; Fey M; Chomienne C; Chevret S; Degos L; Fenaux P;
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and prognosis analysis of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia treated with arsenic trioxide as the front-line therapy.
    Lou Y; Suo S; Tong H; Ye X; Wang Y; Chen Z; Qian W; Meng H; Mai W; Huang J; Tong Y; Jin J
    Leuk Res; 2013 Nov; 37(11):1451-6. PubMed ID: 23958062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of acute promyelocytic leukemia.
    Mele A; Stazi MA; Pulsoni A; Visani G; Monarca B; Castelli G; Rocchi L; Avvisati G; Mandelli F
    Haematologica; 1995; 80(5):405-8. PubMed ID: 8566879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinico-pathological profile of acute promyelocytic leukaemia at Al-Amal Oncology-Haematology Centre, Qatar.
    Ibrahim FA; Yassin MA; El-Ayoubi HR; Alhiji IA; Albinali AS; Almansour SM; Qafoud FM
    East Mediterr Health J; 2010 Sep; 16(9):958-65. PubMed ID: 21218723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration.
    Ribeiro RC; Rego E
    Hematology Am Soc Hematol Educ Program; 2006; ():162-8. PubMed ID: 17124056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukemia in children: experience of the Italian Pediatric Hematology and Oncology Group (AIEOP).
    Biondi A; Rovelli A; Cantù-Rajnoldi A; Fenu S; Basso G; Luciano A; Rondelli R; Mandelli F; Masera G; Testi AM
    Leukemia; 1994; 8 Suppl 2():S66-70. PubMed ID: 7815842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
    Gupta SK; Sazawal S; Mahapatra M; Saxena R
    Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry.
    Pagano L; Stamouli M; Tumbarello M; Verga L; Candoni A; Cattaneo C; Nadali G; Mitra ME; Mancini V; Nosari A; Garzia MG; Delia M; Storti S; Spadea A; Caramatti C; Perriello V; Sanna M; Vacca A; De Paolis MR; Potenza L; Salutari P; Castagnola C; Fanci R; Chierichini A; Melillo L; Picardi M; Facchini L; Martino B; Di Blasi R; Cesarini M; Offidani M; Vianelli N; Caira M; Lessi F; Ferrari A; Venditti A; Pavone V; Lo-Coco F; Aversa F; Busca A;
    Br J Haematol; 2015 Aug; 170(3):434-9. PubMed ID: 25626374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.